Zhejiang Hisun Pharmaceutical Co., Ltd. Class ASSE: 600267

"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by a Subsidiary

Sep 15, 2026 · Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 15, 2026

Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by a Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Zhejiang Hisun Pharmaceutical Co., Ltd. Class A

"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on the Company's Product Passing the U.S. Self-GRAS CertificationSep 12
"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026Sep 11
"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Obtaining New Veterinary Drug Registration Certificate by SubsidiarySep 8
"Zhejiang Hisun Pharmaceutical Co., Ltd."Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2026Sep 4

All Zhejiang Hisun Pharmaceutical Co., Ltd. Class A news releases